# Sodium Bicarbonate

## NaHCO3 300mg

| TAH Drug Code      | [ONAHCO3](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONAHCO3)                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Relief of dyspepsia, Urinary alkalinization, Antacid.                                                                                                                                                                                         |
| Dosing             | Metabolic acidosis, Chronic initial, 600 mg 3 times daily; increase to 4.8g/day (16 tablets). Severe Metabolic acidosis: used IV Sodium Bicarbonate. Urinary alkalinization: 3g every 2 hours, until urine pH>7 .maintain dose 5-10g/day (仿單) |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                 |
| Contraindications  | Metabolic or respiratory alkalosis, hypocalcaemia, hypochlorhydria. Avoid overtreatment.                                                                                                                                                      |
| Adverse Effects    | Metabolic alkalosis; shortness of breath & muscle weakness; muscle hypertonicity, twitching & tetany; Na overloading & hyperosmolality. Stomach cramps & flatulence. Tissue necrosis at inj site.                                             |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                  |

